Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 5289
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
VOTUBIA 2,5MG TBL NOB 10X1
0168455 EU/1/11/710/001 votubia.pdf votubia.pdf L01EG02 R
VOTUBIA 10MG TBL NOB 30X1
0168460 EU/1/11/710/006 votubia.pdf votubia.pdf L01EG02 R
VUMERITY 231MG CPS ETD 360(3X120)
0255277 EU/1/21/1585/002 vumerity.pdf vumerity.pdf L04AX09 R
VUMERITY 231MG CPS ETD 120
0255276 EU/1/21/1585/001 vumerity.pdf vumerity.pdf L04AX09 R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 5
0238217 EU/1/18/1308/003 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 2
0238216 EU/1/18/1308/002 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
VYXEOS LIPOSOMAL 44MG/100MG INF PLV CSL 1
0238215 EU/1/18/1308/001 vyxeoslipo.pdf vyxeoslipo.pdf L01XY01 R
WELDININ 200MG TBL FLM 112
0248844 44/ 205/20-C weldinin.pdf weldinin.pdf L01EX02 R
WELDININ 200MG TBL FLM 112 KAL
0264395 44/ 205/20-C weldinin.pdf weldinin.pdf L01EX02 R
XAGRID 0,5MG CPS DUR 100
0028369 EU/1/04/295/001 xagrid.pdf xagrid.pdf L01XX35 R
XALKORI 250MG CPS DUR 60
0193649 EU/1/12/793/004 xalkori.pdf xalkori.pdf L01ED01 R
XALKORI 200MG CPS DUR 60
0193647 EU/1/12/793/002 xalkori.pdf xalkori.pdf L01ED01 R
XALKORI 200MG CPS DUR 60
0193646 EU/1/12/793/001 xalkori.pdf xalkori.pdf L01ED01 R
XALKORI 250MG CPS DUR 60
0193648 EU/1/12/793/003 xalkori.pdf xalkori.pdf L01ED01 R
XALUPRINE 20MG/ML POR SUS 1X100ML+1AD+2STŘ
0168987 EU/1/11/727/001 xaluprine.pdf xaluprine.pdf L01BB02 R
XELJANZ 5MG TBL FLM 60
0222096 EU/1/17/1178/001 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 11MG TBL PRO 91
0238764 EU/1/17/1178/013 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 5MG TBL FLM 56
0222098 EU/1/17/1178/003 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 5MG TBL FLM 182
0222290 EU/1/17/1178/004 xeljanz.pdf xeljanz.pdf L04AA29 R
XELJANZ 10MG TBL FLM 60
0223058 EU/1/17/1178/005 xeljanz.pdf xeljanz.pdf L04AA29 R

‹‹ ‹ 100 200 210 220 230 240 250 254 255 256 257 258 259 260 261 262 263 264 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 18. January 2022 at 00:08
Last update of price and payment data: 1. January 2022 at 00:11